Forward Pharma A Financials

FWPDelisted Stock  USD 2.56  0.00  0.00%   
Based on the key measurements obtained from Forward Pharma's financial statements, Forward Pharma A is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.
  
Understanding current and past Forward Pharma Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Forward Pharma's financial statements are interrelated, with each one affecting the others. For example, an increase in Forward Pharma's assets may result in an increase in income on the income statement.

Forward Pharma Stock Summary

Forward Pharma competes with Aquestive Therapeutics, Akanda Corp, Stratasys, BCE, and Iridium Communications. Previously, it operated as a biopharmaceutical company that focused on developing FP187 proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. Forward Pharma AS was incorporated in 2005 and is headquartered in Copenhagen, Denmark. Forward Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 4 people.
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS34986J2042
Business AddressOestergade 24A, Copenhagen,
SectorBiotechnology
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.forward-pharma.com
Phone45 33 44 42 42
CurrencyUSD - US Dollar

Forward Pharma Key Financial Ratios

Forward Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Forward Pharma's current stock value. Our valuation model uses many indicators to compare Forward Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Forward Pharma competition to find correlations between indicators driving Forward Pharma's intrinsic value. More Info.
Forward Pharma A is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Forward Pharma by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.

Forward Pharma Market Pulse

 Quote2.56
 Change(%) 0.00  
 Change0.00 
 Open2.56
 Low2.56
 High2.56
 Volume0
 ExchangeNASDAQ

Steps to analyze company Financials for Investing

There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Forward Pharma is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Forward has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it.
In summary, you can determine if Forward Pharma's financials are consistent with your investment objective using the following steps:
  • Review Forward Pharma's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
  • Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
  • Study the cash flow inflows and outflows to understand Forward Pharma's liquidity and solvency.
  • Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
  • Compare Forward Pharma's financials to those of its peers to see how it stacks up and identify any potential red flags.
  • Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Forward Pharma's stock is overvalued or undervalued.
Remember, these are just guidelines and should not be the only basis for investment decisions. It is always important to analyze the leading stock market indicators., conduct additional research and seek professional advice if needed.

Forward Pharma November 29, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Forward Pharma help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Forward Pharma A. We use our internally-developed statistical techniques to arrive at the intrinsic value of Forward Pharma A based on widely used predictive technical indicators. In general, we focus on analyzing Forward Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Forward Pharma's daily price indicators and compare them against related drivers.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.
You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Consideration for investing in Forward Stock

If you are still planning to invest in Forward Pharma A check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Forward Pharma's history and understand the potential risks before investing.
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities